[³²P]S1P
|
P614024-25mg
|
Moligand™ |
N/A |
25mg
|
¥ 5999.9
|
期货,请咨询 |
阿拉丁 |
[³²P]MRS2500
|
P614023-5mg
|
Moligand™ |
N/A |
5mg
|
¥ 3999.9
|
期货,请咨询 |
阿拉丁 |
[³²P]MRS2500
|
P614023-25mg
|
Moligand™ |
N/A |
25mg
|
¥ 5999.9
|
期货,请咨询 |
阿拉丁 |
[¹²⁵I]PTA-OH
|
P613942-5mg
|
Moligand™ |
N/A |
5mg
|
¥ 3999.9
|
期货,请咨询 |
阿拉丁 |
[¹²⁵I]PTA-OH
|
P613942-25mg
|
Moligand™ |
N/A |
25mg
|
¥ 5999.9
|
期货,请咨询 |
阿拉丁 |
[¹²⁵I]PD142308
|
P613934-5mg
|
Moligand™ |
N/A |
5mg
|
¥ 3999.9
|
期货,请咨询 |
阿拉丁 |
[¹²⁵I]PD142308
|
P613934-25mg
|
Moligand™ |
N/A |
25mg
|
¥ 5999.9
|
期货,请咨询 |
阿拉丁 |
6-piperidin-4-yloxy-2H-isoquinolin-1-one
|
P613413-5mg
|
Moligand™ |
N/A |
5mg
|
¥ 3999.9
|
期货,请咨询 |
阿拉丁 |
6-piperidin-4-yloxy-2H-isoquinolin-1-one
|
P613413-25mg
|
Moligand™ |
N/A |
25mg
|
¥ 5999.9
|
期货,请咨询 |
阿拉丁 |
PZM21
|
P613035-5mg
|
Moligand™ |
N/A |
5mg
|
¥ 3999.9
|
期货,请咨询 |
阿拉丁 |
PZM21
|
P613035-25mg
|
Moligand™ |
N/A |
25mg
|
¥ 5999.9
|
期货,请咨询 |
阿拉丁 |
PZ-II-029
|
P613034-5mg
|
Moligand™ |
N/A |
5mg
|
¥ 3999.9
|
期货,请咨询 |
阿拉丁 |
PZ-II-029
|
P613034-25mg
|
Moligand™ |
N/A |
25mg
|
¥ 5999.9
|
期货,请咨询 |
阿拉丁 |
pyrrolopyrimidine 48
|
P613031-5mg
|
Moligand™ |
N/A |
5mg
|
¥ 3999.9
|
期货,请咨询 |
阿拉丁 |
pyrrolopyrimidine 48
|
P613031-25mg
|
Moligand™ |
N/A |
25mg
|
¥ 5999.9
|
期货,请咨询 |
阿拉丁 |
pyrrolidine MCHR1 antagonist 1
|
P613030-5mg
|
Moligand™ |
N/A |
5mg
|
¥ 3999.9
|
期货,请咨询 |
阿拉丁 |
pyrrolidine MCHR1 antagonist 1
|
P613030-25mg
|
Moligand™ |
N/A |
25mg
|
¥ 5999.9
|
期货,请咨询 |
阿拉丁 |
吡咯替尼
|
P613029-5mg
|
Moligand™, ≥98% |
1269662-73-8 |
5mg
|
¥ 3658.9
|
现货 |
阿拉丁 |
吡咯替尼
|
P613029-25mg
|
Moligand™, ≥98% |
1269662-73-8 |
25mg
|
¥ 15999.9
|
现货 |
阿拉丁 |
pyridostigmine
|
P613027-5mg
|
Moligand™ |
155-97-5 |
5mg
|
¥ 3999.9
|
期货,请咨询 |
阿拉丁 |
pyridostigmine
|
P613027-25mg
|
Moligand™ |
155-97-5 |
25mg
|
¥ 5999.9
|
期货,请咨询 |
阿拉丁 |
pyrazolopyrimidine 4n
|
P613026-5mg
|
Moligand™ |
N/A |
5mg
|
¥ 3999.9
|
期货,请咨询 |
阿拉丁 |
pyrazolopyrimidine 4n
|
P613026-25mg
|
Moligand™ |
N/A |
25mg
|
¥ 5999.9
|
期货,请咨询 |
阿拉丁 |
Pyrazolo-pyrimidine 14a
|
P613025-5mg
|
Moligand™ |
N/A |
5mg
|
¥ 3999.9
|
期货,请咨询 |
阿拉丁 |